2021 Call for Late-Breaking & Encore Abstracts

ASCPT 2021 Call for Late-Breaking & Encore Abstracts

Pres 2020 S Rahman

Susan Abdel-Rahman, PharmD


SPC 2021 K Momary

Kathryn Momary, PharmD

Scientific Program Committee Chair

ASCPT 2021 Abstract Guidelines

Late-Breaking Abstract Submission Guidelines

Check out the guidelines.

The Late-Breaking and Encore Submission deadline has passed.

NEW THIS YEAR: Due to the significant disruptions to business and research imposed by the COVID-19 pandemic, ASCPT is accepting scientific abstracts that were unable to be submitted by the September 10th deadline. Criteria for submission is the same as for the regular abstract submission window. Please see clarification in the Call for Abstracts & Abstract Guidelines. Accepted Late Breaking abstracts will also be published in the March supplement to Clinical Pharmacology & Therapeutics!”

“All Encore abstracts must present significant, ground-breaking, and innovative findings that were published (in paper or online) as an original research article in a peer-reviewed journal on or after January 1, 2020, and address a question of relevance to clinical pharmacology and therapeutics.
  • The January 1, 2020, cut-off for earliest publication date refers to the first date of publication (e.g., online electronic publication of the accepted article). The citation to this publication needs to be included in the submission.
  • Encore submissions based on findings previously presented solely in abstract form (e.g., as published in conference proceedings) that are not yet published as an original research article in a peer-reviewed journal do not qualify for submission.”
Credit Card payment is required for an abstract submission to be considered complete. ASCPT accepts MasterCard, Visa, and American Express. Abstract submission fees are non-refundable. ASCPT will not refund the difference for Members who pay the Non-Member abstract fee.

Call for Abstracts for the fourth International Transporter Consortium Workshop (ITCW4)
To be considered for presentation at the ITCW4, submit your abstracts to the ASCPT 2021 Annual Meeting. Upon submission, you will be asked whether you want the abstract to be considered for ITCW4 in addition to the ASCPT 2021 Annual Meeting. If you select this option and your abstract is accepted by the ASCPT Scientific Program Committee, your abstract will be further evaluated by the ITCW4 Planning Committee for their acceptance and placement into the ITCW4 event.

Submission Guidelines:
All submission areas must be completed for the abstract submission to be reviewed. Please refer to the Submission Guidelines Document for full details.
  1. Abstract Content
  2. Keywords
  3. Authors
    At the time of submission, the submitting author must know the following information for all authors:
  4. Conflict of Interest
  5. Table or Graphic
  6. Additional Abstract Information
  7. Payment
  8. Affirmations
Additional Information
Review and Notification
All abstracts will be peer reviewed and scored by members of the Scientific Program Committee. Reviewers will use these Guidelines, including the failure criteria, to score the abstracts. All decisions are final and there is no appeal mechanism. Notifications will be sent by email in December 2020 to ONLY the presenting author.

ASCPT Embargo Policy
Information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting, is embargoed until the start of the ASCPT 2021 Annual Meeting. To assist in the promotion of abstracts prior to the Annual Meeting, ASCPT will publish all abstract numbers, titles, and author details online as part of the scientific program prior to publication of the CPT supplement.

Information released prior to this day is a violation of the ASCPT Abstract Embargo Policy and may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy.

Only the presenting author may withdraw an abstract. Requests for withdrawals must be in writing to meetings@ascpt.org.

Abstract Presentation 
All abstract presenters are required to register for the Annual Meeting in the appropriate registration category (member, non-member, trainee/ student) and pay the applicable fees.

If for any reason the presenter is unable to attend the meeting, a substitution must be made with a person already listed as an author on the abstract. The Society does not provide honoraria, travel, or housing reimbursement to attend the Annual Meeting.

Poster 2.0
ASCPT would like to encourage all abstract presenters to utilize this new, ASCPT Board-approved poster format. This new Poster 2.0 template uses less text for easier viewing and more efficient transfer of information.

For more information on poster 2.0 please check out this video or view the infographic below.

Questions can be directed to Diana Tsuji at diana@ascpt.org or Nicole Rockman at nicole@ascpt.org.
ASCPT Poster 2.0
Photo Gallery
Recent News
  • ASCPT Members-Only Webinar Presented by the Pharmacometrics & Pharmacokinetics (PMK) and Regulatory Science (RS) Communities
    January 20, 2021
  • 2020 in the Year-View Mirror: Full Speed Ahead to 2021
    January 18, 2021
  • FDA News: Issue 2, January 2021
    January 13, 2021
Contact Us